Venture capital firm profile
Knife Capital
Investment manager backing African technology companies with strong intellectual property and international expansion potential.

Typically South African companies
considers sub-Saharan Africa. Knife Fund III has a pan-African mandate with a predominant South African focus.
Series A
Growth
High-growth B2B technology, defined product, recurring revenue, strong IP, high margins and governance. Series A funds focus on South Africa; existing offshore structures need a material South African presence and most funding used locally. Typical investments are $600k (ZAR10m) for Series A to $8m for Knife Fund III. Dollar currency is unspecified.
Healthcare & Life Sciences
Typically South African companies
Sources checked
considers sub-Saharan Africa. Knife Fund III has a pan-African mandate with a predominant South African focus.
Sources checked
Series A
Sources checked
Growth
Sources checked
High-growth B2B technology, defined product, recurring revenue, strong IP, high margins and governance. Series A funds focus on South Africa; existing offshore structures need a material South African presence and most funding used locally. Typical investments are $600k (ZAR10m) for Series A to $8m for Knife Fund III. Dollar currency is unspecified.
Sources checked
Healthcare & Life Sciences
As of
Sources checked
Knife Capital invests in African innovation-led companies and supports their international expansion. Its disclosed portfolio includes DataProphet, Snapplify, Kasha and Simera Sense across multiple managed funds. The firm focuses on companies with established products, recurring revenue and defensible intellectual property, combining financing with commercial networks and expertise.
Editorial profile by MoneyMakers. Sources reviewed . Profile source.
Loading profile details…
Investment sectors
Healthcare & Life Sciences · Investment sectors
As of 2026-11-13
Knife Capital official sourceKnife Capital official sourceKnife Capital official sourceLoading recent changes…